Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis

Conclusion
In active MS, an early postpartum treatment strategy should be determined well before delivery. Natalizumab/fingolimod-strategy reduced postpartum relapse hazard from month 3, but none diminished the early postpartum relapse hazard.

Source: Journal of Neurology, Neurosurgery and Psychiatry - January 11, 2024 Category: Neurosurgery Authors: Haben, S., Ciplea, A. I., Tokic, M., Timmesfeld, N., Thiel, S., Gold, R., Langer-Gould, A. M., Hellwig, K. Tags: JNNP Patients' choice, Open access Multiple sclerosis Source Type: research